Psoriasis is a chronic inflammatory skin disease with a complex disease pathway and frequent treatment limitations.Novel Carriers for Psoriasis Management and Pharmacotherapy explores next-generation drug delivery systems that solve the challenges of conventional psoriasis treatments, it also focuses on innovative carrier technologies such as nanostructured lipid carriers, liposomes, ethosomes, and solid lipid nanoparticles that enhance drug penetration, stability, and targeted delivery. It also covers mechanisms of action, clinical trials, patents, and regulatory insights, offering practical direction for future dermatological formulation research.Key Features:* Showcases advanced carrier systems for psoriasis drug delivery.* Demonstrates improved skin penetration and drug stability strategies.* Analyzes clinical and preclinical evidence for novel formulations.* Explains mechanisms behind nanocarrier performance on the skin barrier.* Reviews formulation hurdles like bioavailability and penetration limits.* Summarizes regulatory and patent trends in dermatology drug delivery.Target Readership: Designed for dermatology researchers, formulation scientists, clinicians, and postgraduate students working in skin drug delivery and psoriasis pharmacotherapy.

Psoriasis is a chronic inflammatory skin disease with a complex disease pathway and frequent treatment limitations.Novel Carriers for Psoriasis Management and Pharmacotherapy explores next-generation drug delivery systems that solve the challenges of conventional psoriasis treatments, it also focuses on innovative carrier technologies such as nanostructured lipid carriers, liposomes, ethosomes, and solid lipid nanoparticles that enhance drug penetration, stability, and targeted delivery. It also covers mechanisms of action, clinical trials, patents, and regulatory insights, offering practical direction for future dermatological formulation research.Key Features:* Showcases advanced carrier systems for psoriasis drug delivery.* Demonstrates improved skin penetration and drug stability strategies.* Analyzes clinical and preclinical evidence for novel formulations.* Explains mechanisms behind nanocarrier performance on the skin barrier.* Reviews formulation hurdles like bioavailability and penetration limits.* Summarizes regulatory and patent trends in dermatology drug delivery.Target Readership: Designed for dermatology researchers, formulation scientists, clinicians, and postgraduate students working in skin drug delivery and psoriasis pharmacotherapy.

Psoriasis is a chronic inflammatory skin disease with a complex disease pathway and frequent treatment limitations.Novel Carriers for Psoriasis Management and Pharmacotherapy explores next-generation drug delivery systems that solve the challenges of conventional psoriasis treatments, it also focuses on innovative carrier technologies such as nanostructured lipid carriers, liposomes, ethosomes, and solid lipid nanoparticles that enhance drug penetration, stability, and targeted delivery. It also covers mechanisms of action, clinical trials, patents, and regulatory insights, offering practical direction for future dermatological formulation research.Key Features:* Showcases advanced carrier systems for psoriasis drug delivery.* Demonstrates improved skin penetration and drug stability strategies.* Analyzes clinical and preclinical evidence for novel formulations.* Explains mechanisms behind nanocarrier performance on the skin barrier.* Reviews formulation hurdles like bioavailability and penetration limits.* Summarizes regulatory and patent trends in dermatology drug delivery.Target Readership: Designed for dermatology researchers, formulation scientists, clinicians, and postgraduate students working in skin drug delivery and psoriasis pharmacotherapy.